Distribution and frequency of patient-reported symptomatic adverse events at a comprehensive cancer center.

被引:0
|
作者
Cleveland, Jessica
Hassett, Michael J.
Lee, Sherry
Chua, Isaac S.
Dominici, Laura Stewart
Schrag, Deborah
McCleary, Nadine Jackson
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19117
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Patient-reported sexual adverse drug events on an online platform for medication experiences
    Gordjin, Rineke
    Kriek, Esther
    Wessels, Wendela
    Nicolai, Melianthe P. J.
    Elzevier, Henk W.
    Visser, Loes
    Guchelaar, Henk Jan
    Teichert, Martina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 793 - 794
  • [42] Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events
    de Boysson, Hubert
    Barakat, Clivia
    Dumont, Anael
    Boutemy, Jonathan
    Silva, Nicolas Martin
    Maigne, Gwenola
    Nguyen, Alexandre
    Lavergne, Amandine
    Castan, Paul
    Gallou, Sophie
    Sultan, Audrey
    Deshayes, Samuel
    Aouba, Achille
    RHEUMATOLOGY, 2022, 61 (09) : 3567 - 3575
  • [43] Health Care Provider Factors Associated with Patient-Reported Adverse Events and Harm
    Giardina, Traber D.
    Royse, Kathryn E.
    Khanna, Arushi
    Haskell, Helen
    Hallisy, Julia
    Southwick, Frederick
    Singh, Hardeep
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2020, 46 (05): : 282 - 290
  • [44] Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability
    Henry, N. Lynn
    Rogatko, Andre
    Ganz, Patricia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04) : 430 - +
  • [45] Integration of patient-reported adverse events into a phase II chemotherapy treatment trial
    Basch, Ethan M.
    Pietanza, Maria Catherine
    Kris, Mark G.
    Shaw, Mary
    Sima, Camelia S.
    Rogak, Lauren J.
    Schrag, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] PATIENT-REPORTED OUTCOMES RELATED TO ADVERSE EVENTS DURING RHEUMATOID ARTHRITIS TREATMENT
    Feinberg, B. A.
    Burruss, R. A.
    Olson, T.
    Malik, F.
    Oleru, K.
    Garofalo, D. F.
    VALUE IN HEALTH, 2016, 19 (03) : A237 - A237
  • [47] Utilization of patient assistance programs for oral chemotherapy at a comprehensive cancer center.
    Schwemm, Ann
    Lentz, Michelle
    Shankaran, Veena
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
    Basch, Ethan
    Pugh, Stephanie L.
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Berk, Lawrence
    Fogh, Shannon
    Rogak, Lauren J.
    Gatewood, Marcha
    Reeve, Bryce B.
    Mendoza, Tito R.
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Minasian, Lori M.
    Bennett, Antonia V.
    Setser, Ann
    Schrag, Deborah
    Roof, Kevin
    Moore, Joan K.
    Gergel, Thomas
    Stephans, Kevin
    Rimner, Andreas
    DeNittis, Albert
    Bruner, Deborah Watkins
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 409 - 418
  • [49] Relationship between patient-reported bother from side effects, adverse events and survival in advanced ovarian cancer
    Wenzel, Lari
    Osann, Kathryn
    Cella, David
    Fulci, Giulia
    Birrer, Michael
    QUALITY OF LIFE RESEARCH, 2018, 27 : S45 - S46
  • [50] Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer
    Nyrop, K. A.
    Damone, E. M.
    Deal, A. M.
    Wheeler, S. B.
    Charlot, M.
    Reeve, B. B.
    Basch, E.
    Shachar, S. S.
    Carey, L. A.
    Reeder-Hayes, K. E.
    Dees, E. C.
    Jolly, T. A.
    Kimmick, G. G.
    Karuturi, M. S.
    Reinbolt, R. E.
    Speca, J. C.
    Wood, W. A.
    Muss, H. B.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 409 - 422